Coming from somewhere where biosimilars are SOC for many years, I just find it wild how things are biosimilar wise in th
Tweet Content
Coming from somewhere where biosimilars are SOC for many years, I just find it wild how things are biosimilar wise in the US. Reflected by so many abstracts, including lots of oral presentations, essentially on showing biosimilars work. #ACR24 @RheumNow
Show on Archive Page
On
Display in Search Results
On
PDQ
Off